Voloridge Investment Management LLC Invests $11.83 Million in Tempus AI, Inc. (NASDAQ:TEM)

Voloridge Investment Management LLC acquired a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 350,300 shares of the company's stock, valued at approximately $11,826,000. Voloridge Investment Management LLC owned 0.22% of Tempus AI at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Victory Capital Management Inc. bought a new stake in shares of Tempus AI in the 4th quarter valued at about $216,000. China Universal Asset Management Co. Ltd. bought a new stake in shares of Tempus AI in the 4th quarter valued at about $1,091,000. Wells Fargo & Company MN raised its holdings in shares of Tempus AI by 13.2% in the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock valued at $80,000 after purchasing an additional 278 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Tempus AI in the 4th quarter valued at about $178,000. Finally, abrdn plc bought a new stake in shares of Tempus AI in the 4th quarter valued at about $2,784,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Tempus AI

In other news, Director David R. Epstein sold 990 shares of the company's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $46.83, for a total transaction of $46,361.70. Following the completion of the sale, the director now owns 26,284 shares of the company's stock, valued at $1,230,879.72. This represents a 3.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Andrew Polovin sold 17,552 shares of the company's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $63.43, for a total transaction of $1,113,323.36. Following the sale, the executive vice president now directly owns 138,877 shares of the company's stock, valued at $8,808,968.11. The trade was a 11.22% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 723,042 shares of company stock worth $37,642,690 in the last three months. Company insiders own 27.60% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts recently commented on TEM shares. Needham & Company LLC reiterated a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a research note on Wednesday, May 7th. Wolfe Research lowered shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Piper Sandler boosted their price objective on shares of Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a research note on Thursday, May 15th. Guggenheim reiterated a "buy" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Finally, JPMorgan Chase & Co. lowered shares of Tempus AI from an "overweight" rating to a "neutral" rating and boosted their price objective for the stock from $50.00 to $55.00 in a research note on Tuesday, February 25th. Six research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, Tempus AI currently has an average rating of "Moderate Buy" and an average target price of $63.42.

Tempus AI Stock Performance

Shares of NASDAQ:TEM traded up $0.66 during trading on Friday, hitting $55.09. 6,765,631 shares of the stock traded hands, compared to its average volume of 6,650,877. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The company has a fifty day moving average price of $52.15 and a two-hundred day moving average price of $51.99. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $91.45. The company has a market cap of $9.49 billion and a price-to-earnings ratio of -7.12.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.03. The firm had revenue of $255.74 million during the quarter, compared to analyst estimates of $248.13 million. The company's quarterly revenue was up 75.4% on a year-over-year basis. As a group, equities analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current year.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.